[Summary] Developer of pathogenic microorganism sequencing technology
Yuguo Biotechnology is one of the earliest enterprises in China to deeply engage in pathogenic infection diagnosis, and is also the pathogenic metagenomic sequencing enterprise in the Ministry of Science and Technology's 13th Five-Year National Key R&D Program. The company's core team has extensive experience in the field of gene sequencing, having participated in the Human Microbiome Project, and has published academic papers with a cumulative impact factor of over 600 in the past decade. The cloud-based AI pathogenic microorganism data analysis system PACE independently developed by Yuguo Biotechnology is at an international level. It can deeply integrate sequencing big data and clinical big data, encompasses ultra-high-dimensional feature value analysis and filtering models, and can conduct multi-omics and cross-species genomic big data research and application, achieving a huge competitive advantage of detection result accuracy exceeding 80%.
The Beijing headquarters R&D center covers nearly 4,000 square meters; a sequencing center of the largest scale in Northwest China has been established in Xi'an, with a P2-level biosafety laboratory possessing clinical gene amplification testing qualifications; gene sequencing laboratories and GMP facilities are operated in Beijing, Guangzhou, Shanghai, and Nanjing; and in May 2020, it was awarded the plaque of "Beijing National New Generation Artificial Intelligence Innovation Development Experimental Zone - Intelligent Sequencing Scenario Open Laboratory," established a pan-genome joint laboratory with universities, built the most comprehensive pathogenic genome pan-genome database in China, and cooperated with the Shanghai Institute of Experimental Medicine to help China's experimental medicine in the precise diagnosis of pathogens for major human diseases, infectious diseases, and difficult diseases.
Yuguo Biotechnology has established deep cooperation with clinical medical experts, laboratory experts, and drug resistance gene research experts, and has provided clinical testing, screening, and consulting services for more than 400 tertiary hospitals nationwide. A cumulative total of nearly 50,000 samples have been tested, with the total number of samples ranking among the top globally.
What does Yuguo Biotechnology (Beijing) Co., Ltd. require? Who is Yuguo Biotechnology hiring? Yuguo Biotechnology recruitment: 销售类占比最多占55.2%,其次是质量管理类占20.9%. What education can get in at Yuguo Biotechnology? 大专占比最多占47.8%,其次是本科占34.3%. High education required at Yuguo Biotechnology? 硕士占13.4%. Work experience required at Yuguo Biotechnology? 3-5年占比最多占41.8%,其次是1-3年占26.9%. Where are the job locations at Yuguo Biotechnology? 北京占比最多占64.2%,其次是广州占9%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows